Diagnostic value of iron indices in hemodialysis patients receiving epoetin

Kidney International

Volumn 60, Issue 1, 2001, Pages 300-308

  Kaufman, James S ^{a,b,c,d,e,f,g}   Reda, Domenic J ^{a,b,c,d,e,f,g}   Fye, Carol L ^{a,b,c,d,e,f,g}   Goldfarb, David S ^{a,b,c,d,e,f,g}   Henderson, W G ^a,c   Kleinman, Jack G ^{a,b,c,d,e,f,g}   Vaamonde, Carlos A ^{a,b,c,d,e,f,g}   Kaufman, J S ^c,c   Cxypoliski, R A ^c   London, P ^c   Young, E ^c   Rose, P ^c   Schmitt, G ^c   Bold, K ^c   Briggs, J ^c   Lee, V ^c   Kaji, D ^c   Ohsumi, F M ^c   Chen, H ^c   Ganz, M B ^c   Nurko, S ^c   Linn, D G ^c   Cronin, R E ^c   Kemp, V N ^c   Saklayen, M G ^c   Adams, S ^c   Jenkins, Y J ^c   Davis, M ^c   Sastrasinh, S ^c   Lordi, K A ^c   Nawab, Z ^c   Kepka, B ^c   Dolson, G ^c   Therappel, R ^c   Bonner, A ^c   Hasbargen, H ^c   Nielsen, S C ^c   Frame, A ^c   Shah, G ^c   Lim, D ^c   Vaamonde, C A ^c   Cason, L ^c   Edelstein, J ^c   Serrano, C ^c   Kleinman, J G ^c   Schramm, J ^c   Sheahan Meyer, E ^c   Jackson, B J ^c   Batuman, V ^c   Archie, D M ^c   Goldfarb, D S ^c,c   Discipulo, R ^c   Dixon, T E ^c   Pederson, J A ^c   Albert, T ^c   Jamison, R L ^c   Usi, D L ^c   Palevsky, P M ^c   Baltz Salai, P ^c   Anderson, S ^c   Wolfson, M ^c   Cummings Cosgrove, M ^c   Feldman, G ^c   Katz, M S ^c   Burns, J A ^c   Thomson, S C ^c   Meek, M V ^c   Rosado, C ^c   Carde, P ^c   Bou, J ^c   Michael, U F ^c   Kirlin, L F ^c   Fye, C L ^c   Semlow, D ^a   Anfinsen, L ^a   Mackay, B ^a   Sather, M R ^c   Chacon, F R ^c   Drago, M ^c   Gagne, W H ^c   Steinman, T I ^h   Nissenson, A ⁱ   Swartz, R D ^j   Symons, M ^k   Feussner, J ^a   Berkowitz, S ^a   Huang, P ^a   Deykin, D ^a   Gold, J ^c   more..

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Clinical Research Pharmacy Coordinating Center ^*  (United States)

^d University of New Mexico   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^k IL   (United States)

more..

Author keywords

Anemia; Parenteral iron; Recombinant human erythropoietin; Serum ferritin; Transferrin saturation

Indexed keywords

FERRITIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON THERAPY; KIDNEY FAILURE; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034955115     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.00800.x     Document Type: Article

References (26)

1. Iron management in end-stage renal disease
2. Laboratory diagnosis of iron deficiency anemia: An overview
3. Failure of serum ferritin levels to predict bone-marrow iron content after intravenous iron-dextran therapy
4. The evaluation of iron status in hemodialysis patients
5. Subcutaneous versus intravenous administration of erythropoietin in hemodialysis patients
6. SAS/STAT User's Guide (version 6, vols 1 and 2, 4th ed)
7. NKF-DOQ1 clinical practice guidelines for the treatment of anemia of chronic renal failure
8. Iron status in patients receiving erythropoietin for dialysis-associated anemia
9. A randomized study of iron supplementation in patients treated with erythropoietin
10. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin
11. Serum ferritin concentration in patients receiving maintenance hemodialysis
12. The safety of intravenous iron dextran in hemodialysis patients
13. Serum ferritin concentration: A reliable guide to iron overload in uremic and hemodialyzed patients
14. Serum ferritin and bone-marrow iron stores in patients on maintenance hemodialysis
15. Iron metabolism in haemodialysis patients
16. Diagnosis of iron deficiency anemia in renal failure patients during the posterythropoietin era
17. Evaluation of iron status in patients on chronic hemodialysis: Relative usefulness of bone marrow hemosiderin, serum ferritin, transferrin saturation, mean corpuscular, and red cell protoporphyrin
18. Diagnostic methods
19. Iron deficiency in maintenance hemodialysis patients: Assessment of diagnosis criteria and of three different iron treatments
20. Serum ferritin and iron deficiency in patients on chronic hemodialysis
21. The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients
22. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients
23. Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation
24. An indistinct balance: The safety and efficacy of parenteral iron therapy
25. Parenteral iron use in the management of anemia in end-stage renal disease patients
26. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients